Specialty finance company Hercules Capital (NYSE: HTGC) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.3% year on year to $138.1 million. Its GAAP profit of $0.63 per share was 31.3% above analysts’ consensus estimates.

Is now the time to buy HTGC? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Hercules Capital’s third quarter was shaped by robust originations and disciplined credit underwriting, which management identified as key drivers of performance. CEO Scott Bluestein highlighted record fundings and a continued focus on high-quality, first lien loans, noting, “Our platform momentum continued in Q3 with originations of over $846 million...putting us on pace to exceed our previous full year record.” Management kept a conservative approach, emphasizing risk controls and maintaining strong liquidity despite some early loan repayments and a slightly lower operating margin.

Looking forward, Hercules Capital’s guidance is anchored by expectations for sustained origination activity and strong dividend coverage, even in a declining interest rate environment. Management anticipates further growth in its debt investment portfolio, with Bluestein stating, “We are maintaining our expectation that origination activity will remain strong through year-end.” CFO Seth Meyer added that most loans are now at their contractual floors, suggesting additional rate cuts should have a limited effect on net investment income. The company’s focus remains on selective growth, credit quality, and steady shareholder distributions.

Key Insights from Management’s Remarks

Management credited the quarter’s performance to record originations, balanced deployment across technology and life sciences, and a measured approach to risk and portfolio growth.

• Record origination momentum: The company achieved over $846 million in new commitments and $504.6 million in gross fundings, with the majority directed toward both new and existing portfolio companies. Management noted that this activity was evenly split between technology and life sciences sectors, supporting portfolio diversification.
• Portfolio growth and quality focus: Hercules maintained its high exposure to first lien loans, exceeding 90% of the portfolio. This positioning was emphasized as critical for risk management, especially in an environment where some market competitors have loosened underwriting standards.
• Conservative credit approach: Despite seeing higher early loan repayments, management underscored its refusal to chase riskier deals or relax deal structures. Bluestein described the market as “frothy” in some areas, but stressed Hercules’s commitment to prudent underwriting and structural integrity in transactions.
• Strong liquidity and leverage position: The company ended the quarter with over $1 billion of available liquidity and kept GAAP leverage below the average of its business development company (BDC) peers. This liquidity supports both new originations and the ability to back current portfolio companies.
• Supplemental distributions supported by earnings: Management reiterated their ability to continue paying both base and supplemental dividends, with recent net investment income covering distributions by a wide margin. The company reported significant undistributed spillover earnings, signaling confidence in sustaining future payouts.

Drivers of Future Performance

Hercules expects continued origination strength, stable credit quality, and solid dividend coverage to drive performance, while acknowledging macroeconomic shifts and competitive pressures.

• Origination pipeline remains robust: Management projects strong funding activity into the next quarter, supported by a sizable pipeline and increased commitments already closed early in the fourth quarter. Bluestein noted that the company’s selective approach to new deals should support portfolio growth without sacrificing quality.
• Impact of interest rate environment muted: Meyer explained that with nearly 75% of prime-based loans at their contractual floors, further rate cuts by the Federal Reserve are expected to have minimal impact on net investment income. The company’s core yield guidance remains in the 12% to 12.5% range for the next quarter.
• Credit discipline amid market frothiness: Management remains cautious about market trends, observing competitors taking on riskier structures. Hercules plans to maintain high underwriting standards, which may limit short-term growth but is seen as essential for long-term stability and risk-adjusted returns.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will monitor (1) whether Hercules can sustain its origination pace and maintain high first lien exposure, (2) the impact of further interest rate changes on net investment income as more loans reach their rate floors, and (3) ongoing credit quality in the portfolio relative to industry peers. Progress on supplemental distributions and disciplined underwriting will also serve as key signposts for execution.

Hercules Capital currently trades at $17.85, up from $17.60 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free for active Edge members).

Our Favorite Stocks Right Now

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.